{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:56:55Z","timestamp":1793145415437,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04796-2","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:46:53Z","timestamp":1771411613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic kidney disease in Norwegian primary care: underdiagnosis and undertreatment \u2014 findings from the VISTAKID (Vestfold Investigation of Stage 3\u20135 Kidney Disease) study"],"prefix":"10.1186","volume":"27","author":[{"given":"Sadollah","family":"Abedini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Bjune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea Bjerkestrand","family":"B\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond Geir","family":"Jenssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"4796_CR1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ckj\/sfaa162","volume":"13","author":"DL Vetrano","year":"2020","unstructured":"Vetrano DL, Triassi L, Topinkova E, et al. CKD as the \u201celephant in the room\u201d. Clin Kidney J. 2020;13:504\u201311.","journal-title":"Clin Kidney J"},{"key":"4796_CR2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/ndt\/gfac236","volume":"38","author":"M Briet","year":"2023","unstructured":"Briet M, et al. CKD as the \u201celephant in the room\u201d. Nephrol Dial Transpl. 2023;38:1397\u2013405.","journal-title":"Nephrol Dial Transpl"},{"key":"4796_CR3","unstructured":"Guideline for Coordination of Care for Patients with Chronic Kidney Disease. The GP\u2019s 1-2-3-4 for chronic kidney disease (CKD). National Norwegian CKD guidelines for GPs. Published in Norway February 2023, revision and updated mars 2025."},{"key":"4796_CR4","doi-asserted-by":"publisher","unstructured":"Birkeland KI, Bodegard J, Eriksson JW, et al. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2.4 million patients from 11 countries: the CaReMe CKD study. Lancet Reg Health Eur. 2022;20:100438. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100438.","DOI":"10.1016\/j.lanepe.2022.100438"},{"key":"4796_CR5","doi-asserted-by":"publisher","unstructured":"Hallan SI, Matsushita K, Sang Y, et al. Long-term trends in the prevalence of chronic kidney disease and risk factors in Norway. Kidney Int. 2016;90(3):665\u201373. https:\/\/doi.org\/10.1016\/j.kint.2016.05.019.","DOI":"10.1016\/j.kint.2016.05.019"},{"issue":"11","key":"4796_CR6","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","volume":"34","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dialysis Transplant. 2019;34(11):1803\u201305.","journal-title":"Nephrol Dialysis Transplant"},{"issue":"4S","key":"4796_CR7","first-page":"S1","volume":"105","author":"A Levin","year":"2024","unstructured":"Levin A, et al. KDIGO, 2024 clinical practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S1\u2013197.","journal-title":"Kidney Int"},{"key":"4796_CR8","doi-asserted-by":"publisher","unstructured":"Gasparini A, Evans M, Coresh J, Grams ME, Norin O, Qureshi AR, et al. Prevalence and recognition of chronic kidney disease in Stockholm healthcare. Kidney Int. 2016;89(3):685\u201392. https:\/\/doi.org\/10.1016\/j.kint.2015.10.009.","DOI":"10.1016\/j.kint.2015.10.009"},{"key":"4796_CR9","doi-asserted-by":"publisher","unstructured":"Mannheimer E, J\u00f8rgensen MB, Hommel K, et al. Management and treatment of chronic kidney disease in the Danish lolland-falster health study: focus on renoprotection and cardiovascular disease Prevention. Clin Kidney J. 2025;18(9):sfaF242. https:\/\/doi.org\/10.1093\/ckj\/sfaf242.","DOI":"10.1093\/ckj\/sfaf242"},{"issue":"1","key":"4796_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12875-025-02721-4","volume":"26","author":"M Lindhardt","year":"2025","unstructured":"Lindhardt M, Knudsen ST, Saxild T, Charles M, Borg R. Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study. BMC Prim Care. 2025;26(1):23. https:\/\/doi.org\/10.1186\/s12875-025-02721-4.","journal-title":"BMC Prim Care"},{"key":"4796_CR11","doi-asserted-by":"publisher","first-page":"853868","DOI":"10.1007\/s12325-022-02341-9","volume":"40","author":"N Yagi","year":"2023","unstructured":"Yagi N, Shukunobe T, Nishimura S, Mima A. Experience and daily burden of patients with chronic kidney disease not receiving maintenance dialysis or renal transplantation. Adv Ther. 2023;40:853868.","journal-title":"Adv Ther"},{"issue":"7","key":"4796_CR12","doi-asserted-by":"publisher","first-page":"921928","DOI":"10.1080\/1744666X.2025.2521086","volume":"21","author":"A Mima","year":"2025","unstructured":"Mima A, Nomura A, Yasuzawa T. Update on the pathophysiology and treatment of diabetic kidney disease: a narrative review. Expert Rev Clin Immunol. 2025;21(7):921928.","journal-title":"Expert Rev Clin Immunol"},{"key":"4796_CR13","doi-asserted-by":"publisher","unstructured":"Bakris GL, Agarwal R, Anker SD, et al. Finerenone in reducing kidney failure and disease progression. N Engl J Med. 2020;383(23):2219\u201329. https:\/\/doi.org\/10.1056\/NEJMoa2025845.","DOI":"10.1056\/NEJMoa2025845"},{"key":"4796_CR14","doi-asserted-by":"crossref","unstructured":"Kristensen SL, R\u00f8rth R, Jhund PS, et al. GLP-1 agonists and kidney outcomes in type 2 diabetes. Lancet Diabetes Endocrinol. 2019.7(10):776\u201385","DOI":"10.1016\/S2213-8587(19)30249-9"},{"issue":"10","key":"4796_CR15","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2215\/CJN.04970512","volume":"7","author":"Society of Nephrology Quality, and Patient Safety Task Force","year":"2012","unstructured":"Society of Nephrology Quality, and Patient Safety Task Force. Critical and honest conversations: the evidence behind the \u201cChoosing Wisely\u201d campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol. 2012 Oct;7(10):1664\u201372. https:\/\/doi.org\/10.2215\/CJN.04970512. Epub 2012 Sep 13. PMID: 22977214.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4796_CR16","doi-asserted-by":"publisher","first-page":"c39","DOI":"10.1159\/000151244","volume":"110","author":"RJ Glassock","year":"2008","unstructured":"Glassock RJ, Winearls C. The global burden of chronic kidney disease: how valid are the estimates? Nephron Clin Pract. 2008;110(1):c39\u201346. https:\/\/doi.org\/10.1159\/000151244.","journal-title":"Nephron Clin Pract"},{"issue":"9888","key":"4796_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(13)60687-X.","journal-title":"Lancet"},{"key":"4796_CR18","volume-title":"Action plan for the Prevention and treatment of chronic kidney disease (2011-2015)","author":"Norwegian Directorate of Health","year":"2011","unstructured":"Norwegian Directorate of Health. Action plan for the Prevention and treatment of chronic kidney disease (2011-2015). Oslo: Norwegian Directorate of Health; 2011."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04796-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04796-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04796-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:46:34Z","timestamp":1773416794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04796-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4796"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04796-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was assessed and approved by the Department of Innovation and Research at Vestfold Hospital Trust as quality-assurance research. In accordance with Norwegian regulations and this institutional determination, approval from the Regional Committees for Medical and Health Research Ethics (REK) was not required; the local REK committee acknowledged this assessment. Because the dataset used in this study was fully anonymized, the requirement for individual informed consent was waived. The project was also registered with NSD (now Sikt \u2013 the Norwegian Agency for Shared Services in Education and Research). The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The manuscript contains no images or other information that could identify individual participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}